CytoveneIV (Genentech, Inc.)
Welcome to the PulseAid listing for the Cytovene drug offered from Genentech, Inc.. This Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genentech, Inc. |
| NON-PROPRIETARY NAME: | ganciclovir sodium |
| SUBSTANCE NAME: | GANCICLOVIR SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1989-06-23 |
| END MARKETING DATE: | 0000-00-00 |
Cytovene IV HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cytovene IV from Genentech, Inc. |
| LABELER NAME: | Genentech, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500(mg/10mL) |
| START MARKETING DATE: | 1989-06-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0004-6940_fa6df59c-ef10-4f40-9f14-5c8dceaaa4a0 |
| PRODUCT NDC: | 0004-6940 |
| APPLICATION NUMBER: | NDA019661 |
Other GANCICLOVIR SODIUM Pharmaceutical Manufacturers / Labelers:
